Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma

N-AVD is a highly effective and well-tolerated frontline regimen in OA with cHL across a wide range of geriatric impairments.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-12-11
DOI
https://doi.org/10.1200/jco-24-01278
Citations
14
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.95
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma

Joachim Yahalom, Raphaël Steiner, Paul A. Hamlin, Tatyana A. Feldman et al.
14 citations
Journal of Clinical Oncology
Lymphoma Diagnosis and Treatment
5.95
article

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma

Joachim Yahalom, Raphaël Steiner, Paul A. Hamlin, Tatyana A. Feldman, Kevin A. David, Ariela Noy, Heiko M. Schöder, Paola Ghione, Kerry J. Savage, William Thomas Johnson, Ahmet Doǧan, Jennifer Kimberly Lue, Helen Hancock, Santosha Adipudi Vardhana, Andrew M. Intlekofer, Esther N Drill, Pallawi Torka, Charisse Capadona, Maria Lia Palomba, Colette Owens, Alexander P. Boardman, Zachary D. Epstein‐Peterson, Andrew David Zelenetz, Alison J. Moskowitz, Natasha Galasso, Steven M. Horwitz, Philip C. Caron, Theresa Davey, Gilles Salles, Robert N. Stuver, Anita Kumar, Sarima Subzwari, Lorenzo Falchi, Jin‐Shu Yang, Nivetha Ganesan, Michael L. Post, Leslie Perez
article en
14 citations

Abstract

N-AVD is a highly effective and well-tolerated frontline regimen in OA with cHL across a wide range of geriatric impairments.

Journal of Clinical OncologyVol. 43(8)
BC Cancer Agency (CA), Hackensack University Medical Center (US), Memorial Sloan Kettering Cancer Center (US)
Good health and well-being
Openalex Percentile: Top 3%
Lymphoma Diagnosis and Treatment
5.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.